AMGN vs SBAC · P/E 24, rev $10.05B vs P/E 30, rev $1.42B
Amgen Inc (AMGN) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the AMGN and SBAC stock pages for the full models.
Not investment advice.